Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | heat shock protein 75, putative | 0.0569 | 0.2588 | 0.2588 |
Mycobacterium ulcerans | heat shock protein 90 | 0.1107 | 0.7443 | 1 |
Trichomonas vaginalis | heat shock protein, putative | 0.1107 | 0.7443 | 0.7443 |
Echinococcus multilocularis | heat shock protein 75 kDa, mitochondrial | 0.0569 | 0.2588 | 0.2588 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.0023 | 0.0023 |
Trichomonas vaginalis | heat shock protein, putative | 0.1107 | 0.7443 | 0.7443 |
Trichomonas vaginalis | heat shock protein, putative | 0.0853 | 0.5145 | 0.5145 |
Toxoplasma gondii | Hsp90 domain-containing protein | 0.0569 | 0.2588 | 0.2588 |
Trypanosoma cruzi | heat shock protein 85, putative | 0.1107 | 0.7443 | 0.7443 |
Leishmania major | heat shock protein, putative | 0.0569 | 0.2588 | 0.2588 |
Plasmodium falciparum | endoplasmin, putative | 0.0853 | 0.5145 | 0.5145 |
Plasmodium vivax | heat shock protein 90, putative | 0.0569 | 0.2588 | 0.2588 |
Leishmania major | lipophosphoglycan biosynthetic protein, putative,heat shock protein 90, putative,glucose regulated protein 94, putative | 0.1107 | 0.7443 | 0.7443 |
Brugia malayi | hypothetical protein | 0.0286 | 0.0023 | 0.0023 |
Giardia lamblia | Grp94/Hsp90 | 0.1107 | 0.7443 | 0.7443 |
Plasmodium falciparum | heat shock protein 90, putative | 0.0569 | 0.2588 | 0.2588 |
Trichomonas vaginalis | heat shock protein, putative | 0.1107 | 0.7443 | 0.7443 |
Brugia malayi | Hsp90 protein | 0.0569 | 0.2588 | 0.2588 |
Entamoeba histolytica | 90 kDa heat shock protein, putative | 0.0569 | 0.2588 | 0.2588 |
Trichomonas vaginalis | heat shock protein, putative | 0.0569 | 0.2588 | 0.2588 |
Echinococcus granulosus | heat shock protein heat shock protein 90 alpha | 0.1107 | 0.7443 | 0.7443 |
Onchocerca volvulus | Heat shock protein 75 kDa, mitochondrial homolog | 0.0569 | 0.2588 | 1 |
Mycobacterium leprae | PROBABLE CHAPERONE PROTEIN HTPG (HEAT SHOCK PROTEIN) (HSP90 FAMILY PROTEIN) (HIGH TEMPERATURE PROTEIN G) | 0.1107 | 0.7443 | 1 |
Wolbachia endosymbiont of Brugia malayi | heat shock protein 90 | 0.1107 | 0.7443 | 1 |
Giardia lamblia | Heat shock protein HSP 90-alpha | 0.1107 | 0.7443 | 0.7443 |
Trichomonas vaginalis | endoplasmin, putative | 0.0853 | 0.5145 | 0.5145 |
Plasmodium vivax | heat shock protein, putative | 0.0569 | 0.2588 | 0.2588 |
Schistosoma mansoni | heat shock protein | 0.0569 | 0.2588 | 0.2588 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0286 | 0.0023 | 0.0023 |
Echinococcus granulosus | endoplasmin | 0.1107 | 0.7443 | 0.7443 |
Loa Loa (eye worm) | heat shock protein 75 | 0.0569 | 0.2588 | 0.2588 |
Mycobacterium tuberculosis | Probable chaperone protein HtpG (heat shock protein) (HSP90 family protein) (high temperature protein G) | 0.1107 | 0.7443 | 1 |
Trypanosoma brucei | heat shock protein 84, putative | 0.0569 | 0.2588 | 0.2588 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0286 | 0.0023 | 0.0023 |
Plasmodium falciparum | heat shock protein 90, putative | 0.0569 | 0.2588 | 0.2588 |
Treponema pallidum | heat shock protein 90 | 0.1107 | 0.7443 | 1 |
Echinococcus multilocularis | endoplasmin | 0.1107 | 0.7443 | 0.7443 |
Echinococcus multilocularis | heat shock protein 90 | 0.1107 | 0.7443 | 0.7443 |
Echinococcus granulosus | heat shock protein 75 kDa mitochondrial | 0.0569 | 0.2588 | 0.2588 |
Trypanosoma cruzi | heat shock protein, putative | 0.0569 | 0.2588 | 0.2588 |
Trypanosoma cruzi | heat shock protein 90, putative | 0.082 | 0.4855 | 0.4855 |
Trypanosoma cruzi | heat shock protein 90, putative | 0.1107 | 0.7443 | 0.7443 |
Echinococcus granulosus | heat shock protein 90 | 0.1107 | 0.7443 | 0.7443 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.2818 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 2.5929 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 6.3096 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 63.0957 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.